Voveran D 50 mg Novartis
| Features | |
| Also known as | Diclofenac Sodium |
| Blood pressure | Can increase blood pressure in susceptible individuals |
| Chemical name | Sodium [o-(2,6-dichloroanilino)phenyl]acetate |
| Dosage (medical) | 50 mg to 100 mg daily in two or three divided doses |
| Dosage (sports) | Not typically prescribed for sports-related uses |
| Effects | Reduces pain, swelling, and joint stiffness |
| Formula | C14H10Cl2NNaO2 |
| Half-life | 1.2 to 2 hours |
| Hepatotoxicity | Possible, especially with long-term use |
| Lab Test | Not typically required for monitoring |
| Main action | Reduces inflammation and pain |
| Side effects | Gastrointestinal issues, cardiovascular risk, renal impairment, headache, dizziness |
| Storage conditions | Store at room temperature, away from moisture and heat |
| Strength | 50 mg |
| Substance class | Nonsteroidal anti-inflammatory drug (NSAID) |
| Trade name | Voltaren, Cataflam, Zipsor |
| Use in sports | Occasionally used to manage pain and inflammation |
| Water Retention | Minimal |
| Manufacturer | Novartis |